"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","induction therapy_maintenance therapy:ch1","mayo endoscopic subscore:ch1","study individual number:ch1","tissue:ch1","week (w):ch1"
"GSM1900148","Bp069_Active UC W0_IFX_43","GSM1900148","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 43 before infliximab (IFX) therapy","Homo sapiens","study individual number: 43","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 43 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900148/suppl/GSM1900148_Bp069.CEL.gz","33252","IFX","3","43","colonic mucosal biopsy","W0"
"GSM1900149","Bp072_UC NR W4/6_IFX_43","GSM1900149","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 43 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 43","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 43 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900149/suppl/GSM1900149_Bp072.CEL.gz","33252","IFX","3","43","colonic mucosal biopsy","W4_W6"
"GSM1900150","Bp073_Control_2","GSM1900150","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 2","Homo sapiens","study individual number: 2","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 2","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900150/suppl/GSM1900150_Bp073.CEL.gz","33252","CO","CO","2","colonic mucosal biopsy","CO"
"GSM1900151","Bp075_Control_3","GSM1900151","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 3","Homo sapiens","study individual number: 3","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 3","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900151/suppl/GSM1900151_Bp075.CEL.gz","33252","CO","CO","3","colonic mucosal biopsy","CO"
"GSM1900152","Bp076_Control_4","GSM1900152","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 2","Homo sapiens","study individual number: 4","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 2","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900152/suppl/GSM1900152_Bp076.CEL.gz","33252","CO","CO","4","colonic mucosal biopsy","CO"
"GSM1900153","Bp077_Control_7","GSM1900153","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 2","Homo sapiens","study individual number: 7","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 2","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900153/suppl/GSM1900153_Bp077.CEL.gz","33252","CO","CO","7","colonic mucosal biopsy","CO"
"GSM1900154","Bp079_Active UC W0_IFX_5","GSM1900154","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 5 before infliximab (IFX) therapy","Homo sapiens","study individual number: 5","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 5 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900154/suppl/GSM1900154_Bp079.CEL.gz","33252","IFX","3","5","colonic mucosal biopsy","W0"
"GSM1900155","Bp080_Active UC W0_IFX_45","GSM1900155","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 45 before infliximab (IFX) therapy","Homo sapiens","study individual number: 45","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 45 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900155/suppl/GSM1900155_Bp080.CEL.gz","33252","IFX","3","45","colonic mucosal biopsy","W0"
"GSM1900156","Bp083_UC NR W4/6_IFX_5","GSM1900156","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 5 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 5","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 5 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900156/suppl/GSM1900156_Bp083.CEL.gz","33252","IFX","3","5","colonic mucosal biopsy","W4_W6"
"GSM1900157","Bp084_UC NR W4/6_IFX_45","GSM1900157","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 45 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 45","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 45 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900157/suppl/GSM1900157_Bp084.CEL.gz","33252","IFX","3","45","colonic mucosal biopsy","W4_W6"
"GSM1900158","Bp086_Active UC W0_IFX_57","GSM1900158","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 57 before infliximab (IFX) therapy","Homo sapiens","study individual number: 57","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 57 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900158/suppl/GSM1900158_Bp086.CEL.gz","33252","IFX","3","57","colonic mucosal biopsy","W0"
"GSM1900159","Bp089_Control_1","GSM1900159","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 1","Homo sapiens","study individual number: 1","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 1","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900159/suppl/GSM1900159_Bp089.CEL.gz","33252","CO","CO","1","colonic mucosal biopsy","CO"
"GSM1900160","Bp093_UC R W4/6_IFX_57","GSM1900160","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 57 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 57","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 57 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900160/suppl/GSM1900160_Bp093.CEL.gz","33252","IFX","1","57","colonic mucosal biopsy","W4_W6"
"GSM1900161","Bp1014_UC NR W12_vdz4w_35","GSM1900161","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 35 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 35","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 35 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900161/suppl/GSM1900161_Bp1014.CEL.gz","33252","vdz4w","2","35","colonic mucosal biopsy","W12"
"GSM1900162","Bp1021_UC NR W12_vdz4w_75","GSM1900162","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 75 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 75","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 75 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900162/suppl/GSM1900162_Bp1021.CEL.gz","33252","vdz4w","3","75","colonic mucosal biopsy","W12"
"GSM1900163","Bp1024_UC R W12_vdz4w_37","GSM1900163","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 75 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 37","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 75 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900163/suppl/GSM1900163_Bp1024.CEL.gz","33252","vdz4w","0","37","colonic mucosal biopsy","W12"
"GSM1900164","Bp1025_UC R W12_vdz4w_44","GSM1900164","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 44 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 44","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 44 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900164/suppl/GSM1900164_Bp1025.CEL.gz","33252","vdz4w","1","44","colonic mucosal biopsy","W12"
"GSM1900165","Bp1026_UC NR W12_vdz4w_24","GSM1900165","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 78 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 24","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 78 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900165/suppl/GSM1900165_Bp1026.CEL.gz","33252","vdz4w","3","24","colonic mucosal biopsy","W12"
"GSM1900166","Bp1029_UC NR W12_vdz4w_78","GSM1900166","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 32 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 78","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 32 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900166/suppl/GSM1900166_Bp1029.CEL.gz","33252","vdz4w","2","78","colonic mucosal biopsy","W12"
"GSM1900167","Bp1032_UC NR W12_vdz4w_32","GSM1900167","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 51 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 32","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 51 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900167/suppl/GSM1900167_Bp1032.CEL.gz","33252","vdz4w","3","32","colonic mucosal biopsy","W12"
"GSM1900168","Bp1035_UC NR W12_vdz4w_51","GSM1900168","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 70 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 51","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 70 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900168/suppl/GSM1900168_Bp1035.CEL.gz","33252","vdz4w","2","51","colonic mucosal biopsy","W12"
"GSM1900169","Bp1036_UC NR W12_vdz4w_70","GSM1900169","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 56 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 70","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 56 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900169/suppl/GSM1900169_Bp1036.CEL.gz","33252","vdz4w","3","70","colonic mucosal biopsy","W12"
"GSM1900170","Bp1038_UC R W12_vdz4w_56","GSM1900170","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 56 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 56","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 56 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900170/suppl/GSM1900170_Bp1038.CEL.gz","33252","vdz4w","0","56","colonic mucosal biopsy","W12"
"GSM1900171","Bp1040_UC NR W12_vdz4w_64","GSM1900171","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 64 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 64","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 64 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900171/suppl/GSM1900171_Bp1040.CEL.gz","33252","vdz4w","3","64","colonic mucosal biopsy","W12"
"GSM1900172","Bp106_Active UC W0_IFX_33","GSM1900172","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 33 before infliximab (IFX) therapy","Homo sapiens","study individual number: 33","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 33 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900172/suppl/GSM1900172_Bp106.CEL.gz","33252","IFX","3","33","colonic mucosal biopsy","W0"
"GSM1900173","Bp1060_UC NR W12_vdz4w_71","GSM1900173","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 71 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 71","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 71 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900173/suppl/GSM1900173_Bp1060.CEL.gz","33252","vdz4w","3","71","colonic mucosal biopsy","W12"
"GSM1900174","Bp1075_UC NR W12_vdz4w_26","GSM1900174","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 26 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 26","week (w): W12","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 26 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900174/suppl/GSM1900174_Bp1075.CEL.gz","33252","vdz4w","3","26","colonic mucosal biopsy","W12"
"GSM1900175","Bp109_Active UC W0_IFX_10","GSM1900175","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 10 before infliximab (IFX) therapy","Homo sapiens","study individual number: 10","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 10 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900175/suppl/GSM1900175_Bp109.CEL.gz","33252","IFX","3","10","colonic mucosal biopsy","W0"
"GSM1900176","Bp110_Active UC W0_IFX_19","GSM1900176","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 19 before infliximab (IFX) therapy","Homo sapiens","study individual number: 19","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 19 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900176/suppl/GSM1900176_Bp110.CEL.gz","33252","IFX","3","19","colonic mucosal biopsy","W0"
"GSM1900177","Bp112_UC R W4/6_IFX_33","GSM1900177","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 33 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 33","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 33 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900177/suppl/GSM1900177_Bp112.CEL.gz","33252","IFX","1","33","colonic mucosal biopsy","W4_W6"
"GSM1900178","Bp113_UC NR W4/6_IFX_10","GSM1900178","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 10 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 10","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 10 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900178/suppl/GSM1900178_Bp113.CEL.gz","33252","IFX","3","10","colonic mucosal biopsy","W4_W6"
"GSM1900179","Bp114_UC NR W4/6_IFX_19","GSM1900179","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 19 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 19","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 19 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900179/suppl/GSM1900179_Bp114.CEL.gz","33252","IFX","2","19","colonic mucosal biopsy","W4_W6"
"GSM1900180","Bp115_Active UC W0_IFX_65","GSM1900180","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 65 before infliximab (IFX) therapy","Homo sapiens","study individual number: 65","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 65 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900180/suppl/GSM1900180_Bp115.CEL.gz","33252","IFX","3","65","colonic mucosal biopsy","W0"
"GSM1900181","Bp116_Active UC W0_IFX_53","GSM1900181","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 53 before infliximab (IFX) therapy","Homo sapiens","study individual number: 53","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 53 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900181/suppl/GSM1900181_Bp116.CEL.gz","33252","IFX","2","53","colonic mucosal biopsy","W0"
"GSM1900182","Bp119_UC R W4/6_IFX_65","GSM1900182","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 65 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 65","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 65 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900182/suppl/GSM1900182_Bp119.CEL.gz","33252","IFX","1","65","colonic mucosal biopsy","W4_W6"
"GSM1900183","Bp121_UC NR W4/6_IFX_53","GSM1900183","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 53 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 53","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 53 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900183/suppl/GSM1900183_Bp121.CEL.gz","33252","IFX","2","53","colonic mucosal biopsy","W4_W6"
"GSM1900184","Bp127_Active UC W0_IFX_67","GSM1900184","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 67 before infliximab (IFX) therapy","Homo sapiens","study individual number: 67","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 67 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900184/suppl/GSM1900184_Bp127.CEL.gz","33252","IFX","2","67","colonic mucosal biopsy","W0"
"GSM1900185","Bp128_Active UC W0_IFX_36","GSM1900185","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 36 before infliximab (IFX) therapy","Homo sapiens","study individual number: 36","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 36 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900185/suppl/GSM1900185_Bp128.CEL.gz","33252","IFX","3","36","colonic mucosal biopsy","W0"
"GSM1900186","Bp131_Active UC W0_IFX_60","GSM1900186","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 60 before infliximab (IFX) therapy","Homo sapiens","study individual number: 60","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 60 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900186/suppl/GSM1900186_Bp131.CEL.gz","33252","IFX","2","60","colonic mucosal biopsy","W0"
"GSM1900187","Bp133_UC NR W4/6_IFX_67","GSM1900187","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 67 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 67","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 67 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900187/suppl/GSM1900187_Bp133.CEL.gz","33252","IFX","3","67","colonic mucosal biopsy","W4_W6"
"GSM1900188","Bp134_UC NR W4/6_IFX_36","GSM1900188","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 36 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 36","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 36 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900188/suppl/GSM1900188_Bp134.CEL.gz","33252","IFX","3","36","colonic mucosal biopsy","W4_W6"
"GSM1900189","Bp1340_UC NR W52_vdz4w_35","GSM1900189","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 35 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 35","week (w): W52","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 35 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900189/suppl/GSM1900189_Bp1340.CEL.gz","33252","vdz4w","2","35","colonic mucosal biopsy","W52"
"GSM1900190","Bp135_UC R W4/6_IFX_60","GSM1900190","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 60 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 60","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 60 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900190/suppl/GSM1900190_Bp135.CEL.gz","33252","IFX","0","60","colonic mucosal biopsy","W4_W6"
"GSM1900191","Bp1356_UC NR W52_vdz4w_24","GSM1900191","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 24 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 24","week (w): W52","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 24 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900191/suppl/GSM1900191_Bp1356.CEL.gz","33252","vdz4w","3","24","colonic mucosal biopsy","W52"
"GSM1900192","Bp136_Active UC W0_IFX_66","GSM1900192","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 66 before infliximab (IFX) therapy","Homo sapiens","study individual number: 66","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 66 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900192/suppl/GSM1900192_Bp136.CEL.gz","33252","IFX","3","66","colonic mucosal biopsy","W0"
"GSM1900193","Bp140_UC R W4/6_IFX_66","GSM1900193","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 66 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 66","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 66 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900193/suppl/GSM1900193_Bp140.CEL.gz","33252","IFX","1","66","colonic mucosal biopsy","W4_W6"
"GSM1900194","Bp1408_UC R W12_vdz4w_37","GSM1900194","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 37 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 37","week (w): W52","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 37 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900194/suppl/GSM1900194_Bp1408.CEL.gz","33252","vdz4w","0","37","colonic mucosal biopsy","W52"
"GSM1900195","Bp141_Active UC W0_IFX_31","GSM1900195","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 31 before infliximab (IFX) therapy","Homo sapiens","study individual number: 31","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 31 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900195/suppl/GSM1900195_Bp141.CEL.gz","33252","IFX","3","31","colonic mucosal biopsy","W0"
"GSM1900196","Bp1410_UC NR W52_vdz4w_78","GSM1900196","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 78 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 78","week (w): W52","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 78 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900196/suppl/GSM1900196_Bp1410.CEL.gz","33252","vdz4w","3","78","colonic mucosal biopsy","W52"
"GSM1900197","Bp1428_UC R W12_vdz4w_71","GSM1900197","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 71 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 71","week (w): W52","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 71 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900197/suppl/GSM1900197_Bp1428.CEL.gz","33252","vdz4w","0","71","colonic mucosal biopsy","W52"
"GSM1900198","Bp1429_UC R W12_vdz4w_26","GSM1900198","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 26 week (W) 12 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 26","week (w): W52","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 26 week (W) 12 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900198/suppl/GSM1900198_Bp1429.CEL.gz","33252","vdz4w","1","26","colonic mucosal biopsy","W52"
"GSM1900199","Bp144_UC NR W4/6_IFX_31","GSM1900199","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 31 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 31","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 31 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900199/suppl/GSM1900199_Bp144.CEL.gz","33252","IFX","3","31","colonic mucosal biopsy","W4_W6"
"GSM1900200","Bp1450_UC NR W52_vdz4w_64","GSM1900200","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 64 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 64","week (w): W52","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 64 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900200/suppl/GSM1900200_Bp1450.CEL.gz","33252","vdz4w","3","64","colonic mucosal biopsy","W52"
"GSM1900201","Bp1473_UC R W52_vdz4w_56","GSM1900201","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 56 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 56","week (w): W52","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 56 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900201/suppl/GSM1900201_Bp1473.CEL.gz","33252","vdz4w","1","56","colonic mucosal biopsy","W52"
"GSM1900202","Bp148_Active UC W0_IFX_23","GSM1900202","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 23 before infliximab (IFX) therapy","Homo sapiens","study individual number: 23","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 23 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900202/suppl/GSM1900202_Bp148.CEL.gz","33252","IFX","3","23","colonic mucosal biopsy","W0"
"GSM1900203","Bp151_UC NR W4/6_IFX_23","GSM1900203","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 23 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 23","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 23 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900203/suppl/GSM1900203_Bp151.CEL.gz","33252","IFX","3","23","colonic mucosal biopsy","W4_W6"
"GSM1900204","Bp154_Active UC W0_IFX_38","GSM1900204","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 38 before infliximab (IFX) therapy","Homo sapiens","study individual number: 38","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 38 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900204/suppl/GSM1900204_Bp154.CEL.gz","33252","IFX","3","38","colonic mucosal biopsy","W0"
"GSM1900205","Bp155_UC R W4/6_IFX_38","GSM1900205","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 38 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 38","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 38 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900205/suppl/GSM1900205_Bp155.CEL.gz","33252","IFX","0","38","colonic mucosal biopsy","W4_W6"
"GSM1900206","Bp156_Active UC W0_IFX_9","GSM1900206","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 9 before infliximab (IFX) therapy","Homo sapiens","study individual number: 9","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 9 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900206/suppl/GSM1900206_Bp156.CEL.gz","33252","IFX","3","9","colonic mucosal biopsy","W0"
"GSM1900207","Bp159_UC NR W4/6_IFX_9","GSM1900207","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 9 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 9","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 9 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900207/suppl/GSM1900207_Bp159.CEL.gz","33252","IFX","2","9","colonic mucosal biopsy","W4_W6"
"GSM1900208","Bp164_Active UC W0_IFX_11","GSM1900208","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 11 before infliximab (IFX) therapy","Homo sapiens","study individual number: 11","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 11 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900208/suppl/GSM1900208_Bp164.CEL.gz","33252","IFX","3","11","colonic mucosal biopsy","W0"
"GSM1900209","Bp167_UC NR W4/6_IFX_11","GSM1900209","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 11 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 11","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 11 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900209/suppl/GSM1900209_Bp167.CEL.gz","33252","IFX","3","11","colonic mucosal biopsy","W4_W6"
"GSM1900210","Bp168_Active UC W0_IFX_46","GSM1900210","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 46 before infliximab (IFX) therapy","Homo sapiens","study individual number: 46","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 46 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900210/suppl/GSM1900210_Bp168.CEL.gz","33252","IFX","3","46","colonic mucosal biopsy","W0"
"GSM1900211","Bp170_Control_7","GSM1900211","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 7","Homo sapiens","study individual number: 7","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 7","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900211/suppl/GSM1900211_Bp170.CEL.gz","33252","CO","CO","7","colonic mucosal biopsy","CO"
"GSM1900212","Bp179_UC R W4/6_IFX_46","GSM1900212","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 46 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 46","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 46 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900212/suppl/GSM1900212_Bp179.CEL.gz","33252","IFX","1","46","colonic mucosal biopsy","W4_W6"
"GSM1900213","Bp185_Active UC W0_IFX_72","GSM1900213","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 72 before infliximab (IFX) therapy","Homo sapiens","study individual number: 72","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 72 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900213/suppl/GSM1900213_Bp185.CEL.gz","33252","IFX","2","72","colonic mucosal biopsy","W0"
"GSM1900214","Bp190_Active UC W0_IFX_48","GSM1900214","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 48 before infliximab (IFX) therapy","Homo sapiens","study individual number: 48","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 48 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900214/suppl/GSM1900214_Bp190.CEL.gz","33252","IFX","3","48","colonic mucosal biopsy","W0"
"GSM1900215","Bp191_Active UC W0_IFX_27","GSM1900215","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 27 before infliximab (IFX) therapy","Homo sapiens","study individual number: 27","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 27 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900215/suppl/GSM1900215_Bp191.CEL.gz","33252","IFX","3","27","colonic mucosal biopsy","W0"
"GSM1900216","Bp192_UC R W4/6_IFX_72","GSM1900216","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 72 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 72","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 72 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900216/suppl/GSM1900216_Bp192.CEL.gz","33252","IFX","0","72","colonic mucosal biopsy","W4_W6"
"GSM1900217","Bp197_Active UC W0_IFX_8","GSM1900217","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 8 before infliximab (IFX) therapy","Homo sapiens","study individual number: 8","week (w): W0","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 8 before infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900217/suppl/GSM1900217_Bp197.CEL.gz","33252","IFX","3","8","colonic mucosal biopsy","W0"
"GSM1900218","Bp201_UC NR W4/6_IFX_27","GSM1900218","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 27 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 27","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 27 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900218/suppl/GSM1900218_Bp201.CEL.gz","33252","IFX","3","27","colonic mucosal biopsy","W4_W6"
"GSM1900219","Bp204_UC NR W4/6_IFX_48","GSM1900219","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 48 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 48","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 48 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900219/suppl/GSM1900219_Bp204.CEL.gz","33252","IFX","3","48","colonic mucosal biopsy","W4_W6"
"GSM1900220","Bp207_UC NR W4/6_IFX_8","GSM1900220","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 8 week (W) 4-6 after infliximab (IFX) therapy","Homo sapiens","study individual number: 8","week (w): W4_W6","induction therapy_maintenance therapy: IFX","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 8 week (W) 4-6 after infliximab (IFX) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900220/suppl/GSM1900220_Bp207.CEL.gz","33252","IFX","2","8","colonic mucosal biopsy","W4_W6"
"GSM1900221","Bp607_Control_21","GSM1900221","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 21","Homo sapiens","study individual number: 21","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 21","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900221/suppl/GSM1900221_Bp607.CEL.gz","33252","CO","CO","21","colonic mucosal biopsy","CO"
"GSM1900222","Bp609_Control_14","GSM1900222","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 14","Homo sapiens","study individual number: 14","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 14","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900222/suppl/GSM1900222_Bp609.CEL.gz","33252","CO","CO","14","colonic mucosal biopsy","CO"
"GSM1900223","Bp610_Control_52","GSM1900223","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 52","Homo sapiens","study individual number: 52","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 52","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900223/suppl/GSM1900223_Bp610.CEL.gz","33252","CO","CO","52","colonic mucosal biopsy","CO"
"GSM1900224","Bp611_Control_25","GSM1900224","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 25","Homo sapiens","study individual number: 25","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 25","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900224/suppl/GSM1900224_Bp611.CEL.gz","33252","CO","CO","25","colonic mucosal biopsy","CO"
"GSM1900225","Bp615_Control_12","GSM1900225","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 12","Homo sapiens","study individual number: 12","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 12","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900225/suppl/GSM1900225_Bp615.CEL.gz","33252","CO","CO","12","colonic mucosal biopsy","CO"
"GSM1900226","Bp616_Control_6","GSM1900226","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from control individual 6","Homo sapiens","study individual number: 6","week (w): CO","induction therapy_maintenance therapy: CO","mayo endoscopic subscore: CO","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from control individual 6","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900226/suppl/GSM1900226_Bp616.CEL.gz","33252","CO","CO","6","colonic mucosal biopsy","CO"
"GSM1900227","Bp771_Active UC W0_vdz_vdz8w_15","GSM1900227","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 15 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 15","week (w): W0","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 15 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900227/suppl/GSM1900227_Bp771.CEL.gz","33252","vdz_vdz8w","3","15","colonic mucosal biopsy","W0"
"GSM1900228","BP772_UC NR W6_vdz_vdz8w_15","GSM1900228","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 15 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 15","week (w): W6","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 15 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900228/suppl/GSM1900228_BP772.CEL.gz","33252","vdz_vdz8w","2","15","colonic mucosal biopsy","W6"
"GSM1900229","Bp773_UC R W52_vdz_vdz8w_15","GSM1900229","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 15 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 15","week (w): W52","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 15 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900229/suppl/GSM1900229_Bp773.CEL.gz","33252","vdz_vdz8w","0","15","colonic mucosal biopsy","W52"
"GSM1900230","Bp774_Active UC W0_vdz_vdz4w_20","GSM1900230","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 20 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 20","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 20 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900230/suppl/GSM1900230_Bp774.CEL.gz","33252","vdz_vdz4w","3","20","colonic mucosal biopsy","W0"
"GSM1900231","Bp775_UC NR W6_vdz_vdz4w_20","GSM1900231","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 20 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 20","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 20 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900231/suppl/GSM1900231_Bp775.CEL.gz","33252","vdz_vdz4w","3","20","colonic mucosal biopsy","W6"
"GSM1900232","Bp776_UC other (earlier stop W8)_vdz_vdz4w_20","GSM1900232","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 20 week (W) 8 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 20","week (w): W8","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 20 week (W) 8 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900232/suppl/GSM1900232_Bp776.CEL.gz","33252","vdz_vdz4w","3","20","colonic mucosal biopsy","W8"
"GSM1900233","Bp778_Active UC W0_vdz_vdz4w_22","GSM1900233","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 22 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 22","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 22 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900233/suppl/GSM1900233_Bp778.CEL.gz","33252","vdz_vdz4w","3","22","colonic mucosal biopsy","W0"
"GSM1900234","Bp779_UC NR W6_vdz_vdz4w_22","GSM1900234","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 22 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 22","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 22 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900234/suppl/GSM1900234_Bp779.CEL.gz","33252","vdz_vdz4w","3","22","colonic mucosal biopsy","W6"
"GSM1900235","Bp780_UC other (earlier stop W8)_vdz_vdz4w_22","GSM1900235","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 22 week (W) 8 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 22","week (w): W8","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 22 week (W) 8 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900235/suppl/GSM1900235_Bp780.CEL.gz","33252","vdz_vdz4w","3","22","colonic mucosal biopsy","W8"
"GSM1900236","Bp781_Active UC W0_vdz_vdz4w_28","GSM1900236","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 28 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 28","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 28 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900236/suppl/GSM1900236_Bp781.CEL.gz","33252","vdz_vdz4w","3","28","colonic mucosal biopsy","W0"
"GSM1900237","Bp782_UC R W6_vdz_vdz4w_28","GSM1900237","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 28 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 28","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 28 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900237/suppl/GSM1900237_Bp782.CEL.gz","33252","vdz_vdz4w","1","28","colonic mucosal biopsy","W6"
"GSM1900238","Bp783_UC R W52_vdz_vdz4w_28","GSM1900238","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 28 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 28","week (w): W52","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 28 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900238/suppl/GSM1900238_Bp783.CEL.gz","33252","vdz_vdz4w","0","28","colonic mucosal biopsy","W52"
"GSM1900239","Bp784_Active UC W0_plac_plac_29","GSM1900239","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 29 before placebo (plac) therapy","Homo sapiens","study individual number: 29","week (w): W0","induction therapy_maintenance therapy: plac_plac","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 29 before placebo (plac) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900239/suppl/GSM1900239_Bp784.CEL.gz","33252","plac_plac","3","29","colonic mucosal biopsy","W0"
"GSM1900240","Bp785_UC other (W6 placebo)_plac_plac_29","GSM1900240","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 29 week (W) 6 after placebo (plac) therapy","Homo sapiens","study individual number: 29","week (w): W6","induction therapy_maintenance therapy: plac_plac","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 29 week (W) 6 after placebo (plac) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900240/suppl/GSM1900240_Bp785.CEL.gz","33252","plac_plac","3","29","colonic mucosal biopsy","W6"
"GSM1900241","Bp792_Active UC W0_vdz_vdz4w_54","GSM1900241","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 54 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 54","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 54 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900241/suppl/GSM1900241_Bp792.CEL.gz","33252","vdz_vdz4w","3","54","colonic mucosal biopsy","W0"
"GSM1900242","Bp793_UC NR W6_vdz_vdz4w_54","GSM1900242","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 54 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 54","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 54 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900242/suppl/GSM1900242_Bp793.CEL.gz","33252","vdz_vdz4w","3","54","colonic mucosal biopsy","W6"
"GSM1900243","Bp794_UC other (earlier stop W8)_vdz_vdz4w_54","GSM1900243","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 54 week (W) 8 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 54","week (w): W8","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 54 week (W) 8 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900243/suppl/GSM1900243_Bp794.CEL.gz","33252","vdz_vdz4w","3","54","colonic mucosal biopsy","W8"
"GSM1900244","Bp795_Active UC W0_vdz_vdz8w_59","GSM1900244","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 59 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 59","week (w): W0","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 59 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900244/suppl/GSM1900244_Bp795.CEL.gz","33252","vdz_vdz8w","3","59","colonic mucosal biopsy","W0"
"GSM1900245","Bp796_UC NR W6_vdz_vdz8w_59","GSM1900245","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 59 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 59","week (w): W6","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 59 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900245/suppl/GSM1900245_Bp796.CEL.gz","33252","vdz_vdz8w","3","59","colonic mucosal biopsy","W6"
"GSM1900246","Bp797_Active UC W0_plac_plac_61","GSM1900246","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 61 before placebo (plac) therapy","Homo sapiens","study individual number: 61","week (w): W0","induction therapy_maintenance therapy: plac_plac","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 61 before placebo (plac) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900246/suppl/GSM1900246_Bp797.CEL.gz","33252","plac_plac","3","61","colonic mucosal biopsy","W0"
"GSM1900247","Bp798_UC other (W6 placebo)_plac_plac_61","GSM1900247","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 61 week (W) 6 after placebo (plac) therapy","Homo sapiens","study individual number: 61","week (w): W6","induction therapy_maintenance therapy: plac_plac","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 61 week (W) 6 after placebo (plac) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900247/suppl/GSM1900247_Bp798.CEL.gz","33252","plac_plac","1","61","colonic mucosal biopsy","W6"
"GSM1900248","Bp799_Active UC W0_vdz_vdz4w_63","GSM1900248","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 63 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 63","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 63 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900248/suppl/GSM1900248_Bp799.CEL.gz","33252","vdz_vdz4w","3","63","colonic mucosal biopsy","W0"
"GSM1900249","Bp800_UC NR W6_vdz_vdz4w_63","GSM1900249","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 63 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 63","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 63 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900249/suppl/GSM1900249_Bp800.CEL.gz","33252","vdz_vdz4w","2","63","colonic mucosal biopsy","W6"
"GSM1900250","Bp801_UC other (earlier stop W28)_vdz_vdz4w_63","GSM1900250","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 63 week (W) 28 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 63","week (w): W28","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 63 week (W) 28 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900250/suppl/GSM1900250_Bp801.CEL.gz","33252","vdz_vdz4w","3","63","colonic mucosal biopsy","W28"
"GSM1900251","Bp802_Active UC W0_vdz_vdz4w_68","GSM1900251","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 68 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 68","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 68 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900251/suppl/GSM1900251_Bp802.CEL.gz","33252","vdz_vdz4w","3","68","colonic mucosal biopsy","W0"
"GSM1900252","Bp803_UC NR W6_vdz_vdz4w_68","GSM1900252","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 68 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 68","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 68 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900252/suppl/GSM1900252_Bp803.CEL.gz","33252","vdz_vdz4w","3","68","colonic mucosal biopsy","W6"
"GSM1900253","Bp804_UC other (earlier stop W9)_vdz_vdz4w_68","GSM1900253","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 68 week (W) 9 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 68","week (w): W9","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 68 week (W) 9 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900253/suppl/GSM1900253_Bp804.CEL.gz","33252","vdz_vdz4w","3","68","colonic mucosal biopsy","W9"
"GSM1900254","Bp805_Active UC W0_plac_plac_69","GSM1900254","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 69 before placebo (plac) therapy","Homo sapiens","study individual number: 69","week (w): W0","induction therapy_maintenance therapy: plac_plac","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 69 before placebo (plac) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900254/suppl/GSM1900254_Bp805.CEL.gz","33252","plac_plac","2","69","colonic mucosal biopsy","W0"
"GSM1900255","Bp806_UC other (W6 placebo)_plac_plac_69","GSM1900255","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 69 week (W) 6 after placebo (plac) therapy","Homo sapiens","study individual number: 69","week (w): W6","induction therapy_maintenance therapy: plac_plac","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 69 week (W) 6 after placebo (plac) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900255/suppl/GSM1900255_Bp806.CEL.gz","33252","plac_plac","3","69","colonic mucosal biopsy","W6"
"GSM1900256","Bp807_UC other (W14 placebo)_plac_plac_69","GSM1900256","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 69 week (W) 14 after placebo (plac) therapy","Homo sapiens","study individual number: 69","week (w): W14","induction therapy_maintenance therapy: plac_plac","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 69 week (W) 14 after placebo (plac) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900256/suppl/GSM1900256_Bp807.CEL.gz","33252","plac_plac","3","69","colonic mucosal biopsy","W14"
"GSM1900257","Bp808_Active UC W0_vdz_vdz4w_74","GSM1900257","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 74 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 74","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 74 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900257/suppl/GSM1900257_Bp808.CEL.gz","33252","vdz_vdz4w","3","74","colonic mucosal biopsy","W0"
"GSM1900258","Bp809_UC NR W6_vdz_vdz4w_74","GSM1900258","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 74 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 74","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 74 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900258/suppl/GSM1900258_Bp809.CEL.gz","33252","vdz_vdz4w","3","74","colonic mucosal biopsy","W6"
"GSM1900259","Bp810_UC other (earlier stop W38)_vdz_vdz4w_74","GSM1900259","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 74 week (W) 38 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 74","week (w): W38","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 74 week (W) 38 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900259/suppl/GSM1900259_Bp810.CEL.gz","33252","vdz_vdz4w","2","74","colonic mucosal biopsy","W38"
"GSM1900260","Bp813_Active UC W0_vdz_plac_73","GSM1900260","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 73 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 73","week (w): W0","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 73 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900260/suppl/GSM1900260_Bp813.CEL.gz","33252","vdz_plac","2","73","colonic mucosal biopsy","W0"
"GSM1900261","Bp814_UC R W6_vdz_plac_73","GSM1900261","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 73 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 73","week (w): W6","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 73 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900261/suppl/GSM1900261_Bp814.CEL.gz","33252","vdz_plac","0","73","colonic mucosal biopsy","W6"
"GSM1900262","Bp815_UC R W52_vdz_plac_73","GSM1900262","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 73 week (W) 52 after VDZ_placebo therapy","Homo sapiens","study individual number: 73","week (w): W52","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 73 week (W) 52 after VDZ_placebo therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900262/suppl/GSM1900262_Bp815.CEL.gz","33252","vdz_plac","0","73","colonic mucosal biopsy","W52"
"GSM1900263","Bp816_Active UC W0_vdz_plac_30","GSM1900263","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 30 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 30","week (w): W0","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 30 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900263/suppl/GSM1900263_Bp816.CEL.gz","33252","vdz_plac","3","30","colonic mucosal biopsy","W0"
"GSM1900264","Bp818_UC NR W52_vdz_plac_30","GSM1900264","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 30 week (W) 52 after VDZ_placebo therapy","Homo sapiens","study individual number: 30","week (w): W52","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 30 week (W) 52 after VDZ_placebo therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900264/suppl/GSM1900264_Bp818.CEL.gz","33252","vdz_plac","2","30","colonic mucosal biopsy","W52"
"GSM1900265","Bp820_Active UC W0_vdz_vdz4w_34","GSM1900265","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 34 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 34","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 34 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900265/suppl/GSM1900265_Bp820.CEL.gz","33252","vdz_vdz4w","2","34","colonic mucosal biopsy","W0"
"GSM1900266","Bp821_UC R W6_vdz_vdz4w_34","GSM1900266","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 34 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 34","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 34 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900266/suppl/GSM1900266_Bp821.CEL.gz","33252","vdz_vdz4w","0","34","colonic mucosal biopsy","W6"
"GSM1900267","Bp822_UC R W52_vdz_vdz4w_34","GSM1900267","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 34 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 34","week (w): W52","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 34 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900267/suppl/GSM1900267_Bp822.CEL.gz","33252","vdz_vdz4w","1","34","colonic mucosal biopsy","W52"
"GSM1900268","Bp823_Active UC W0_vdz_vdz4w_50","GSM1900268","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 50 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 50","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 50 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900268/suppl/GSM1900268_Bp823.CEL.gz","33252","vdz_vdz4w","2","50","colonic mucosal biopsy","W0"
"GSM1900269","Bp824_UC NR W6_vdz_vdz4w_50","GSM1900269","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 50 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 50","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 50 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900269/suppl/GSM1900269_Bp824.CEL.gz","33252","vdz_vdz4w","3","50","colonic mucosal biopsy","W6"
"GSM1900270","Bp825_UC R W52_vdz_vdz4w_50","GSM1900270","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 50 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 50","week (w): W52","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 50 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900270/suppl/GSM1900270_Bp825.CEL.gz","33252","vdz_vdz4w","0","50","colonic mucosal biopsy","W52"
"GSM1900271","Bp826_Active UC W0_vdz_vdz4w_42","GSM1900271","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 42 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 42","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 42 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900271/suppl/GSM1900271_Bp826.CEL.gz","33252","vdz_vdz4w","3","42","colonic mucosal biopsy","W0"
"GSM1900272","Bp827_UC NR W6_vdz_vdz4w_42","GSM1900272","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 42 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 42","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 42 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900272/suppl/GSM1900272_Bp827.CEL.gz","33252","vdz_vdz4w","3","42","colonic mucosal biopsy","W6"
"GSM1900273","Bp828_UC R W52_vdz_vdz4w_42","GSM1900273","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 42 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 42","week (w): W52","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 42 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900273/suppl/GSM1900273_Bp828.CEL.gz","33252","vdz_vdz4w","1","42","colonic mucosal biopsy","W52"
"GSM1900274","Bp829_Active UC W0_vdz_vdz4w_18","GSM1900274","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 18 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 18","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 18 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900274/suppl/GSM1900274_Bp829.CEL.gz","33252","vdz_vdz4w","3","18","colonic mucosal biopsy","W0"
"GSM1900275","Bp830_UC NR W6_vdz_vdz4w_18","GSM1900275","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 18 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 18","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 18 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900275/suppl/GSM1900275_Bp830.CEL.gz","33252","vdz_vdz4w","3","18","colonic mucosal biopsy","W6"
"GSM1900276","Bp831_UC other (earlier stop W32)_vdz_vdz4w_18","GSM1900276","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 18 week (W) 32 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 18","week (w): W32","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 18 week (W) 32 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900276/suppl/GSM1900276_Bp831.CEL.gz","33252","vdz_vdz4w","3","18","colonic mucosal biopsy","W32"
"GSM1900277","Bp835_Active UC W0_vdz_vdz4w_47","GSM1900277","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 47 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 47","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 47 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900277/suppl/GSM1900277_Bp835.CEL.gz","33252","vdz_vdz4w","3","47","colonic mucosal biopsy","W0"
"GSM1900278","Bp836_UC NR W6_vdz_vdz4w_47","GSM1900278","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 47 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 47","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 47 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900278/suppl/GSM1900278_Bp836.CEL.gz","33252","vdz_vdz4w","3","47","colonic mucosal biopsy","W6"
"GSM1900279","Bp837_UC R W52_vdz_vdz4w_47","GSM1900279","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 47 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 47","week (w): W52","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 47 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900279/suppl/GSM1900279_Bp837.CEL.gz","33252","vdz_vdz4w","0","47","colonic mucosal biopsy","W52"
"GSM1900280","Bp838_Active UC W0_vdz_vdz4w_49","GSM1900280","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 49 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 49","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 49 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900280/suppl/GSM1900280_Bp838.CEL.gz","33252","vdz_vdz4w","3","49","colonic mucosal biopsy","W0"
"GSM1900281","Bp839_UC R W6_vdz_vdz4w_49","GSM1900281","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 49 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 49","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 49 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900281/suppl/GSM1900281_Bp839.CEL.gz","33252","vdz_vdz4w","1","49","colonic mucosal biopsy","W6"
"GSM1900282","Bp840_UC R W52_vdz_vdz4w_49","GSM1900282","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 49 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 49","week (w): W52","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 49 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900282/suppl/GSM1900282_Bp840.CEL.gz","33252","vdz_vdz4w","0","49","colonic mucosal biopsy","W52"
"GSM1900283","Bp841_Active UC W0_vdz_vdz4w_58","GSM1900283","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 58 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 58","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 58 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900283/suppl/GSM1900283_Bp841.CEL.gz","33252","vdz_vdz4w","2","58","colonic mucosal biopsy","W0"
"GSM1900284","Bp842_UC NR W6_vdz_vdz4w_58","GSM1900284","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 58 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 58","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 58 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900284/suppl/GSM1900284_Bp842.CEL.gz","33252","vdz_vdz4w","2","58","colonic mucosal biopsy","W6"
"GSM1900285","Bp843_Active UC W0_vdz_vdz4w_39","GSM1900285","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 39 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 39","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 39 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900285/suppl/GSM1900285_Bp843.CEL.gz","33252","vdz_vdz4w","3","39","colonic mucosal biopsy","W0"
"GSM1900286","Bp844_UC NR W6_vdz_vdz4w_39","GSM1900286","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 39 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 39","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 39 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900286/suppl/GSM1900286_Bp844.CEL.gz","33252","vdz_vdz4w","3","39","colonic mucosal biopsy","W6"
"GSM1900287","Bp845_UC other (earlier stop W18)_vdz_vdz4w_39","GSM1900287","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 39 week (W) 18 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 39","week (w): W18","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 39 week (W) 18 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900287/suppl/GSM1900287_Bp845.CEL.gz","33252","vdz_vdz4w","3","39","colonic mucosal biopsy","W18"
"GSM1900288","Bp850_Active UC W0_vdz_vdz4w_13","GSM1900288","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 13 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 13","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 13 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900288/suppl/GSM1900288_Bp850.CEL.gz","33252","vdz_vdz4w","3","13","colonic mucosal biopsy","W0"
"GSM1900289","Bp851_UC NR W6_vdz_vdz4w_13","GSM1900289","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 13 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 13","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 13 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900289/suppl/GSM1900289_Bp851.CEL.gz","33252","vdz_vdz4w","3","13","colonic mucosal biopsy","W6"
"GSM1900290","Bp852_UC other (earlier stop W16)_vdz_vdz4w_13","GSM1900290","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 13 week (W) 16 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 13","week (w): W16","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 13 week (W) 16 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900290/suppl/GSM1900290_Bp852.CEL.gz","33252","vdz_vdz4w","3","13","colonic mucosal biopsy","W16"
"GSM1900291","Bp853_Active UC W0_vdz_vdz4w_16","GSM1900291","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 16 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 16","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 16 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900291/suppl/GSM1900291_Bp853.CEL.gz","33252","vdz_vdz4w","2","16","colonic mucosal biopsy","W0"
"GSM1900292","Bp854_UC NR W6_vdz_vdz4w_16","GSM1900292","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 16 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 16","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 16 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900292/suppl/GSM1900292_Bp854.CEL.gz","33252","vdz_vdz4w","2","16","colonic mucosal biopsy","W6"
"GSM1900293","Bp855_UC other (earlier stop W28)_vdz_vdz4w_16","GSM1900293","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 16 week (W) 28 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 16","week (w): W28","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 16 week (W) 28 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900293/suppl/GSM1900293_Bp855.CEL.gz","33252","vdz_vdz4w","1","16","colonic mucosal biopsy","W28"
"GSM1900294","Bp856_Active UC W0_vdz_vdz4w_76","GSM1900294","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 76 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 76","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 76 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900294/suppl/GSM1900294_Bp856.CEL.gz","33252","vdz_vdz4w","2","76","colonic mucosal biopsy","W0"
"GSM1900295","Bp857_UC NR W6_vdz_vdz4w_76","GSM1900295","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 76 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 76","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 76 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900295/suppl/GSM1900295_Bp857.CEL.gz","33252","vdz_vdz4w","2","76","colonic mucosal biopsy","W6"
"GSM1900296","Bp858_UC NR W52_vdz_vdz4w_76","GSM1900296","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 76 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 76","week (w): W52","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 76 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900296/suppl/GSM1900296_Bp858.CEL.gz","33252","vdz_vdz4w","2","76","colonic mucosal biopsy","W52"
"GSM1900297","Bp859_Active UC W0_vdz_vdz4w_55","GSM1900297","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 55 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 55","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 55 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900297/suppl/GSM1900297_Bp859.CEL.gz","33252","vdz_vdz4w","2","55","colonic mucosal biopsy","W0"
"GSM1900298","Bp860_UC NR W6_vdz_vdz4w_55","GSM1900298","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 55 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 55","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 55 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900298/suppl/GSM1900298_Bp860.CEL.gz","33252","vdz_vdz4w","2","55","colonic mucosal biopsy","W6"
"GSM1900299","Bp861_Active UC W0_vdz_plac_17","GSM1900299","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 17 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 17","week (w): W0","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 17 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900299/suppl/GSM1900299_Bp861.CEL.gz","33252","vdz_plac","3","17","colonic mucosal biopsy","W0"
"GSM1900300","Bp862_UC R W6_vdz_plac_17","GSM1900300","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 17 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 17","week (w): W6","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 0","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 17 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900300/suppl/GSM1900300_Bp862.CEL.gz","33252","vdz_plac","0","17","colonic mucosal biopsy","W6"
"GSM1900301","Bp863_UC other (earlier stop W10, placebo)_vdz_plac_17","GSM1900301","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 17 week (W) 10 after VDZ_placebo therapy","Homo sapiens","study individual number: 17","week (w): W10","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 17 week (W) 10 after VDZ_placebo therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900301/suppl/GSM1900301_Bp863.CEL.gz","33252","vdz_plac","3","17","colonic mucosal biopsy","W10"
"GSM1900302","Bp864_Active UC W0_vdz_vdz4w_77","GSM1900302","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 77 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 77","week (w): W0","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 77 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900302/suppl/GSM1900302_Bp864.CEL.gz","33252","vdz_vdz4w","2","77","colonic mucosal biopsy","W0"
"GSM1900303","Bp865_UC NR W6_vdz_vdz4w_77","GSM1900303","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 77 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 77","week (w): W6","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 77 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900303/suppl/GSM1900303_Bp865.CEL.gz","33252","vdz_vdz4w","2","77","colonic mucosal biopsy","W6"
"GSM1900304","Bp866_UC R W52_vdz_vdz4w_77","GSM1900304","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 77 week (W) 52 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 77","week (w): W52","induction therapy_maintenance therapy: vdz_vdz4w","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 77 week (W) 52 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900304/suppl/GSM1900304_Bp866.CEL.gz","33252","vdz_vdz4w","1","77","colonic mucosal biopsy","W52"
"GSM1900305","Bp868_Active UC W0_vdz_plac_62","GSM1900305","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 62 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 62","week (w): W0","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 62 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900305/suppl/GSM1900305_Bp868.CEL.gz","33252","vdz_plac","2","62","colonic mucosal biopsy","W0"
"GSM1900306","Bp869_UC R W6_vdz_plac_62","GSM1900306","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC responder (R) 62 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 62","week (w): W6","induction therapy_maintenance therapy: vdz_plac","mayo endoscopic subscore: 1","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC responder (R) 62 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900306/suppl/GSM1900306_Bp869.CEL.gz","33252","vdz_plac","1","62","colonic mucosal biopsy","W6"
"GSM1900307","Bp872_Active UC W0_vdz_vdz8w_41","GSM1900307","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 41 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 41","week (w): W0","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 41 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900307/suppl/GSM1900307_Bp872.CEL.gz","33252","vdz_vdz8w","3","41","colonic mucosal biopsy","W0"
"GSM1900308","Bp873_UC NR W6_vdz_vdz8w_41","GSM1900308","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 41 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 41","week (w): W6","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 41 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900308/suppl/GSM1900308_Bp873.CEL.gz","33252","vdz_vdz8w","2","41","colonic mucosal biopsy","W6"
"GSM1900309","Bp874_UC other (earlier stop W26)_vdz_vdz8w_41","GSM1900309","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 41 week (W) 26 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 41","week (w): W26","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 41 week (W) 26 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900309/suppl/GSM1900309_Bp874.CEL.gz","33252","vdz_vdz8w","3","41","colonic mucosal biopsy","W26"
"GSM1900310","Bp878_Active UC W0_vdz_vdz8w_40","GSM1900310","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 40 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 40","week (w): W0","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 40 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900310/suppl/GSM1900310_Bp878.CEL.gz","33252","vdz_vdz8w","2","40","colonic mucosal biopsy","W0"
"GSM1900311","Bp879_UC NR W6_vdz_vdz8w_40","GSM1900311","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC non-responder (NR) 40 week (W) 6 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 40","week (w): W6","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC non-responder (NR) 40 week (W) 6 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900311/suppl/GSM1900311_Bp879.CEL.gz","33252","vdz_vdz8w","2","40","colonic mucosal biopsy","W6"
"GSM1900312","Bp880_UC other (earlier stop W8)_vdz_vdz8w_40","GSM1900312","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from UC patient 40 week (W) 8 after vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 40","week (w): W8","induction therapy_maintenance therapy: vdz_vdz8w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from UC patient 40 week (W) 8 after vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900312/suppl/GSM1900312_Bp880.CEL.gz","33252","vdz_vdz8w","2","40","colonic mucosal biopsy","W8"
"GSM1900313","Bp892_Active UC W0_vdz4w_37","GSM1900313","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 37 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 37","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 37 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900313/suppl/GSM1900313_Bp892.CEL.gz","33252","vdz4w","3","37","colonic mucosal biopsy","W0"
"GSM1900314","Bp898_Active UC W0_vdz4w_44","GSM1900314","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 44 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 44","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 44 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900314/suppl/GSM1900314_Bp898.CEL.gz","33252","vdz4w","2","44","colonic mucosal biopsy","W0"
"GSM1900315","Bp903_Active UC W0_vdz4w_75","GSM1900315","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 75 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 75","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 75 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900315/suppl/GSM1900315_Bp903.CEL.gz","33252","vdz4w","3","75","colonic mucosal biopsy","W0"
"GSM1900316","Bp904_Active UC W0_vdz4w_78","GSM1900316","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 78 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 78","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 78 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900316/suppl/GSM1900316_Bp904.CEL.gz","33252","vdz4w","3","78","colonic mucosal biopsy","W0"
"GSM1900317","Bp906_Active UC W0_vdz4w_24","GSM1900317","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 24 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 24","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 24 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900317/suppl/GSM1900317_Bp906.CEL.gz","33252","vdz4w","2","24","colonic mucosal biopsy","W0"
"GSM1900318","Bp913_Active UC W0_vdz4w_32","GSM1900318","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 32 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 32","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 32 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900318/suppl/GSM1900318_Bp913.CEL.gz","33252","vdz4w","3","32","colonic mucosal biopsy","W0"
"GSM1900319","Bp918_Active UC W0_vdz4w_51","GSM1900319","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 51 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 51","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 51 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900319/suppl/GSM1900319_Bp918.CEL.gz","33252","vdz4w","2","51","colonic mucosal biopsy","W0"
"GSM1900320","Bp925_Active UC W0_vdz4w_64","GSM1900320","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 64 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 64","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 64 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900320/suppl/GSM1900320_Bp925.CEL.gz","33252","vdz4w","3","64","colonic mucosal biopsy","W0"
"GSM1900321","Bp926_Active UC W0_vdz4w_56","GSM1900321","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 56 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 56","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 56 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900321/suppl/GSM1900321_Bp926.CEL.gz","33252","vdz4w","3","56","colonic mucosal biopsy","W0"
"GSM1900322","Bp932_Active UC W0_vdz4w_71","GSM1900322","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 71 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 71","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 71 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900322/suppl/GSM1900322_Bp932.CEL.gz","33252","vdz4w","2","71","colonic mucosal biopsy","W0"
"GSM1900323","Bp940_Active UC W0_vdz4w_35","GSM1900323","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 35 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 35","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 35 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900323/suppl/GSM1900323_Bp940.CEL.gz","33252","vdz4w","2","35","colonic mucosal biopsy","W0"
"GSM1900324","Bp941_Active UC W0_vdz4w_70","GSM1900324","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 70 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 70","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 2","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 70 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900324/suppl/GSM1900324_Bp941.CEL.gz","33252","vdz4w","2","70","colonic mucosal biopsy","W0"
"GSM1900325","Bp950_Active UC W0_vdz4w_26","GSM1900325","Public on Oct 11 2016","Oct 01 2015","Oct 11 2016","RNA","1","Colonic mucosal biopsy from active UC patient 26 before vedolizumab (VDZ) therapy","Homo sapiens","study individual number: 26","week (w): W0","induction therapy_maintenance therapy: vdz4w","mayo endoscopic subscore: 3","tissue: colonic mucosal biopsy","total RNA","Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Benelux B.V.), according to the manufacturer’s instructions.","biotin","Biotin-labeled single-stranded DNA was synthesized using the Affymetrix GeneChip WT terminal Labeling kit (Affymetrix), according to manufacturer's instructions.","9606","After fragmentation of DNA, labeled DNA was hybridized for 16h at 45°C on Affymetrix Human Gene 1.0 ST arrays.","The arrays were washed and stained in a fluidics station using the GeneChip hybridization, Wash end Stain kit (Affymetrix) and scanned using the Affymetrix 3000 GeneScanner.","Colonic mucosal biopsy from active UC patient 26 before vedolizumab (VDZ) therapy","Probe level analysis was performed on the Affymetrix raw data (.cel files) with the robust multichip average (RMA) method implemented in the Bioconductor package 'aroma.affymetrix' to obtain a log2 expression value for each gene probe set","GPL6244","Ingrid,,Arijs","ingrid.arijs@med.kuleuven.be","TARGID - IBD Leuven","Clinical and Experimental Medicine","KULeuven","Herestraat 49","Leuven","3000","Belgium","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1900nnn/GSM1900325/suppl/GSM1900325_Bp950.CEL.gz","33252","vdz4w","3","26","colonic mucosal biopsy","W0"
